Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.

Mult Scler Int · 2019 · PMC6350531 · PMID 30775037

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

In other comparisons the 24-month ARR was lower with GA compared with teriflunomide and dimethyl fumarate, and the relative risk of disability worsening was lower for GA compared with teriflunomide and fingolimod, but these failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.